Dlbcl Diffuse Large B Cell Lymphoma | List of Frontiers open access articles

Brief Research Report

Published on 05 Nov 2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

in Hematologic Malignancies

Guido Gini
Alice Di Rocco
Luca Nassi
Annalisa Arcari
Maria Chiara Tisi
Giacomo Loseto
Attilio Olivieri
Massimo Gentile
Ombretta Annibali
Maria Giuseppina Cabras

Frontiers in Oncology

doi 10.3389/fonc.2021.730194

4,706 views

Brief Research Report

Published on 28 Apr 2023

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

in Hematologic Malignancies

Adrián Mosquera Orgueira
Jose Ángel Díaz Arías
Rocio Serrano Martín
Victor Portela Piñeiro
Miguel Cid López
Andrés Peleteiro Raíndo
Laura Bao Pérez
Marta Sonia González Pérez
Manuel Mateo Pérez Encinas
Máximo Francisco Fraga Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1157646

2,854 views
5 citations

Original Research

Published on 02 Dec 2021

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

in Hematologic Malignancies

Ajay Gogia
Sukesh Nair
Shalabh Arora
Lalit Kumar
Atul Sharma
Ritu Gupta
Ahitagni Biswas
Saumyaranjan Mallick

Frontiers in Oncology

doi 10.3389/fonc.2021.770747

4,245 views
9 citations

Systematic Review

Published on 18 Jul 2024

A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Kanwal Asghar
Maryam Zafar
Eva Holland
Ali Bin Abduljabbar
Sara A. Albagoush
Noureen Asghar
Akshat Sood
Jalal M. Dufani
Joseph Thirumalaredy
Bradley DeVrieze

Frontiers in Oncology

doi 10.3389/fonc.2024.1407001

4,851 views
2 citations

Case Report

Published on 16 Mar 2022

Coexistence of Pituitary Adenoma and Primary Pituitary Lymphoma: A Case Report and Review of the Literature

in Neurosurgery

Shangjun Ren
Qingyang Lu
Yilei Xiao
Yiming Zhang
Lianqun Zhang
Bin Li
Mengyou Li

Frontiers in Surgery

doi 10.3389/fsurg.2022.842830

3,496 views
9 citations

Original Research

Published on 14 Feb 2022

Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers

in Hematologic Malignancies

Lingshuang Sheng
Di Fu
Yiwen Cao
Yujia Huo
Shuo Wang
Rong Shen
Pengpeng Xu
Shu Cheng
Li Wang
Weili Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.790720

4,685 views
10 citations

Mini Review

Published on 08 Jul 2021

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma

in Virology

Hiroshi Kimura
Yusuke Okuno
Yoshitaka Sato
Takahiro Watanabe
Takayuki Murata

Frontiers in Microbiology

doi 10.3389/fmicb.2021.667968

6,648 views
22 citations

Original Research

Published on 04 Feb 2026

In the diffuse large B-cell lymphoma microenvironment, SIRT1 is upregulated and correlated with a pro-inflammatory macrophage signature and autophagy-related gene expression

in Cancer Immunity and Immunotherapy

Miguel Resanoa
Peio Azcoaga
Naike Salvador
Alba Delgado
Claudia Rodiño
Matthieu Schoenhals
Mounia S. Braza

Frontiers in Immunology

doi 10.3389/fimmu.2026.1701514

823 views

Review

Published on 18 May 2022

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL

in Alloimmunity and Transplantation

Nikeshan Jeyakumar
Melody Smith

Frontiers in Immunology

doi 10.3389/fimmu.2022.887866

7,384 views
12 citations

Review

Published on 22 Oct 2024

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Naseem Esteghamat
Aaron Tsumura
Gabriel Marquez-Arreguin
Joseph Tuscano

Frontiers in Oncology

doi 10.3389/fonc.2024.1481950

4,377 views
1 citation

Original Research

Published on 16 Jun 2025

Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure

in Cancer Immunity and Immunotherapy

Ying-Yu Dong
Qing Shi
Wen Wu
Bing-Bing Zhao
Di Fu
Peng-Peng Xu
Shu Cheng
Guilhem Bousquet
Wei-Li Zhao
Li Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1553850

4,436 views
2 citations

Original Research

Published on 07 Jun 2021

Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling

in Cancer Immunity and Immunotherapy

Yamel Cardona Gloria
Stephan H. Bernhart
Sven Fillinger
Olaf-Oliver Wolz
Sabine Dickhöfer
Jakob Admard
Stephan Ossowski
Sven Nahnsen
Reiner Siebert
Alexander N. R. Weber

Frontiers in Immunology

doi 10.3389/fimmu.2021.616451

6,844 views
11 citations

Review

Published on 12 Apr 2021

The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies

in B Cell Biology

Prerna Malaney
María Velasco-Estevez
Pedro Aguilar-Garrido
Marisa J. L. Aitken
Lauren E. Chan
Xiaorui Zhang
Sean M. Post
Miguel Gallardo

Frontiers in Immunology

doi 10.3389/fimmu.2021.634584

6,007 views
3 citations

Original Research

Published on 28 Feb 2022

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

in Hematologic Malignancies

Willem Daneels
Michael Rosskamp
Gilles Macq
Estabraq Ismael Saadoon
Anke De Geyndt
Fritz Offner
Hélène A. Poirel

Frontiers in Oncology

doi 10.3389/fonc.2022.824704

8,633 views
15 citations

Review

Published on 19 Feb 2026

Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma

in Pharmacology of Anti-Cancer Drugs

Shuran Zhang
Jiye Liu
Zengjun Li

Frontiers in Oncology

doi 10.3389/fonc.2026.1696105

1,004 views

Editorial

Published on 17 Mar 2021

Editorial: Genomics of Lymphoproliferative Disease

in Hematologic Malignancies

Francesco Maura
Luca Agnelli
Stefania Bortoluzzi

Frontiers in Oncology

doi 10.3389/fonc.2021.660016

2,696 views

Articles

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma

Coexistence of Pituitary Adenoma and Primary Pituitary Lymphoma: A Case Report and Review of the Literature

Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma

In the diffuse large B-cell lymphoma microenvironment, SIRT1 is upregulated and correlated with a pro-inflammatory macrophage signature and autophagy-related gene expression

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure

Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling

The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma

Editorial: Genomics of Lymphoproliferative Disease